July 21 (Reuters) - Sumitomo Dainippon Pharma Co Ltd 4506.T
* Sunovion's Latuda (lurasidone HCI) receives Health Canada approval to treat adolescents with schizophrenia
* Sunovion's Latuda receives Health Canada approval to treat adolescents with schizophrenia